Fabrication of cesium-137 brachytherapy sources using vitrification technology

Cancer Biotherapy and Radiopharmaceuticals

Volumn 24, Issue 4, 2009, Pages 489-502

  Dash, Ashutosh ^a   Varma, R N ^a   Ram, Ramu ^a   Saxena, S K ^a   Mathakar, A R ^a   Avhad, B G ^a   Sastry, K V S ^b   Sangurdekar, P R ^a   Venkatesh, Meera ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

^b Board of Radiation and Isotope Technology (BRIT)   (India)

Author keywords

Borosilicate glass; Brachytherapy source; Cesium 137; Immobilization; Leaching; Low dose rate brachytherapy; Permanent mould casting

Indexed keywords

BORIC ACID; CESIUM 137; CESIUM NITRATE; GLASS; MELAMINE; PLATINUM; SILICON DIOXIDE; SILVER NITRATE; SODIUM BOROSILICATE; SODIUM DERIVATIVE; SODIUM NITRATE; STAINLESS STEEL; UNCLASSIFIED DRUG; VERMICULITE;

ARTICLE; AUTORADIOGRAPHY; BRACHYTHERAPY; ENCAPSULATION; EQUIPMENT DESIGN; FURNACE; IMMOBILIZATION; LARGE SCALE PRODUCTION; LEACHING; MATERIAL COATING; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; SAFETY; UTERINE CERVIX CANCER; VITRIFICATION; VOLATILIZATION;

BRACHYTHERAPY; CESIUM RADIOISOTOPES; FEMALE; GLASS; HUMANS; RADIOCHEMISTRY; RADIOTHERAPY DOSAGE; UTERINE CERVICAL NEOPLASMS;

EID: 69249121292     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2008.0583     Document Type: Article

References (36)

1. Notani PN. Global variation in cancer incidence and mortality, Curr Sci 2001;81:465.
2. Murthy NS, Chaudhry K, Saxena S. Trends in cervical cancer incidence-Indian scenario. Eur J Cancer Prev 2005;14:513.
3. Paul AM, Waggoner S, Rotmensch J, et al. Cervical cancer in the elderly treated with radiation therapy. Gynecol Oncol 1998;71:291.
4. Husseinzadeh N, van Aken ML, Aron B. Ovarian transposition in young patients with invasive cervical cancer receiving radiation therapy. Int J Gynecol Cancer 1994;4:61.
5. Bell MC, Davidson SA, Mathis JM, et al. Topotecan concomitant with primary brachytherapy radiation in patients with cervical carcinoma: A phase I trial. Gynecol Oncol 2001;80:128.
6. Perez CA, Grisby PW, Camel HM, et al. Irradiation alone or combined with surgery in stage IB, IIA, and IIIB carcinoma of uterine cervix: Update of a nonrandomized comparison. Int J Radiat Oncol Biol Phys 1995;31:703.
7. Arterbery VE. High-dose rate brachytherapy for carcinoma of the cervix. Curr Opin Oncol 1993;5:1005.
8. Pierquin B, Wilson JF, Chassagne D. In: Pierquin B, Wilson JF, Chassagne D, eds. Cervix Brachytherapy: Modem Brachytherapy. New York: Masson, 1987;175.
9. Lambin I, Gerbaulet A, Kramar A, et al. Phase III trial comparing two low-dose rates in brachytherapy of cervix carcinoma: Report 2 years. Int J Radiat Oncol Biol Phys 1993;25:405.
10. Nori D, Merimsky O, Batata M, et al. Postoperative highdose- rate intravaginal brachytherapy combined with external irradiation for early-stage endometrial cancer: A long-term follow-up. Int J Radiat Oncol Biol Phys 1994;30:831.
11. Zablow A, Adams M, Gregori C, et al. Stage II adenocarcinoma of the endometrium treated by two standard regimens of combined preoperative irradiation and surgery. Int J Gynecol Cancer 1994;4:265.
12. Sakata K, Hareyama M, Yama N, et al. Long survival of patients with unresectable cervical carcinoma after radiotherapy. Jpn J Clin Oncol 1997; 27:285.
13. Nickers P, Kunklerand I, Scalliet P. Modern brachytherapy: Current state and future prospects. Eur J Cancer 1997;33:1747.
14. Williamson JF. Brachytherapy technology and physics practice since 1950: A half-century of progress, Phys Med Biol 2006;51:303.
15. Brady WL, Bizhan M, Miyamoto CT, et al. Innovations in brachytherapy in gynecologic oncology. Cancer 2006;76:2143.
16. 137Cs brachytherapy in renal-sparing irradiation of bilateral Wilms tumor. Int J Radiat Oncol Biol Phys 1997;39:1121.
17. 137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix. Brachytherapy. 2003;2:85.
18. Kumar PP, Good RR, McCaul GF. Applicator for use of cesium-137 miniaturized tube sources in the treatment of uterine cervix cancer. Int J Radiat Oncol Biol Phys 1990;18:1509.
19. Bateman TJ, Davy TJ, Skeggs DB. Five years' hospital experience with the Amersham caesium-137 manual afterloading system. Br J Radiol 1983;18:1053.
20. Law RC, Mohamed AS, Maguire RB. Treatment time for Amersham caesium-137 manual afterloading system. Comput Biol Med 1992;22:337.
21. Atkinson WJ, Brezovich IA. Analytic solution for source distributions in brachytherapy to obtain uniform dose rates in spherical tumor models. Phys Med Biol 2007;52:5871.
22. 137Cs sources in lowdose-rate brachytherapy at the oncology unit in the Hospital General de Mexico. Radiat Prot Dosim 2006;120(1-4):95.
23. Casal E, Ballester F, Lluch JL, et al. Monte Carlo calculations of dose-rate distributions around the Amersham CDCS-Mtype 137Cs source. Med Phys 2000;27:132.
24. Baker C, Dini SA, Kudrimoti M, et al. Dosimetric evaluation of a newly designed low-dose-rate brachytherapy applicator for treatment of cervical cancer with extension into the lower vagina. J Appl Clin Med Phys 2007;8:37.
25. Poynter AJ. Direct measurement of air kerma rate in air from CDCS J-type caesium-137 therapy sources using a Farmer ionization chamber. Br J Radiol 2000;73:425.
26. Bownes P. Principles and practice of brachytherapy-using afterloading systems. Br J Radiol 2003;76:80.
27. Kaushik CP, Mishra RK, Sengupta P, et al. Barium borosilicate glass-a potential matrix for immobilization of sulfate bearing high-level radioactive liquid waste. J Nucl Mat 2006;358(2-3):129.
28. Karlina OK, Ovchinnikov AV, Ozhovan MI. Immobilization of sulfate-containing wastes in borosilicate glass using fluoride additives. Atom Energy 1994;76:165.
29. Boccaccini AR, Berthier T, Seglem S. Encapsulated gadolinium zirconate pyrochlore particles in soda borosilicate glass as novel radioactive waste form. Ceram Int 2007;33:1231.
30. Hrma P, Crum JV, Bates DJ, et al. Vitrification and testing of a Hanford high-level waste sample. Part 1: Glass fabrication and chemical and radiochemical analysis. J Nucl Mat 2005;345:19.
31. Forsberg CW, Beahm EC, Parker GW, et al. Conversion of radioactive and hazardous chemical wastes into borosilicate glass using the glass material oxidation and dissolution system, Waste Manage. 1996;16:615.
32. Meegoda JN, Ezeldin AS, Fang Hsai-Yang, et al. Waste immobilization technologies, practice periodical of hazardous, toxic, and radioactive waste management. 2003;7:46.
33. AERB. AERB Safety standard no.: AERB=SS=3 (Rev.1), class. of sealed sources. Mumbai, India: Atomic Energy Regulatory Board, Department of Atomic Energy, 2001.
34. Dash A, Deodhar AS, Varma RN, et al. Development of vermiculite-based glass for fabrication of cesium-137 sources. Ind J Tech 1993;31:823.
35. Darling AS, Selman GL. Platinum-clad equipment for handling molten glass. plat Met Rev, 1968;12:92.
36. Dinshaw KA. Technological adaptation in the practice of radiotherapy in developing countries. Eighteenth UICC International Cancer Conference June 30-July 5, 2002. Int J Cancer 2002;100(S13):60.